{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:08:52Z","timestamp":1785449332363,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011447","name":"Science and Technology Department of Henan Province","doi-asserted-by":"publisher","award":["225200810068"],"award-info":[{"award-number":["225200810068"]}],"id":[{"id":"10.13039\/501100011447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.neuroscience.2026.02.013","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T08:16:12Z","timestamp":1771402572000},"page":"94-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The retinal nerve fiber layer mean thickness in patients with early Parkinson\u2019s disease reflects striatal dopamine function"],"prefix":"10.1016","volume":"599","author":[{"given":"Xiaoxue","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5825-1927","authenticated-orcid":false,"given":"Jianjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingge","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonghan","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaopu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.013_b0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.parkreldis.2014.11.007","article-title":"Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice","volume":"21","author":"Ba","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.013_b0010","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/mds.25844","article-title":"Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease","volume":"29","author":"Berg","year":"2014","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.02.013_b0015","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/ana.24182","article-title":"Alpha-synuclein in the inner retina in Parkinson disease","volume":"75","author":"Bodis-Wollner","year":"2014","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.013_b0020","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10072-019-03738-1","article-title":"Plasma alpha-synuclein levels in patients with Parkinson's disease: a systematic review and meta-analysis","volume":"40","author":"Bougea","year":"2019","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.013_b0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"Pt 5","key":"10.1016\/j.neuroscience.2026.02.013_b0030","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/brain\/113.5.1539","article-title":"The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET","volume":"113","author":"Brooks","year":"1990","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.013_b0035","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.21541","article-title":"A critical evaluation of the Braak staging scheme for Parkinson's disease","volume":"64","author":"Burke","year":"2008","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.013_b0040","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mds.26479","article-title":"Synaptic failure and alpha-synuclein","volume":"31","author":"Calo","year":"2016","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.013_b0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","article-title":"Gut-seeded alpha-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice","volume":"23","author":"Challis","year":"2020","journal-title":"Nat. Neurosci."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.02.013_b0050","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00415-017-8588-7","article-title":"Non-CNS pathogenic origin of Parkinson's disease","volume":"264","author":"Choudhry","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuroscience.2026.02.013_b0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.parkreldis.2019.04.023","article-title":"Retinal layers in Parkinson's disease: a meta-analysis of spectral-domain optical coherence tomography studies","volume":"64","author":"Chrysou","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.013_b0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.14802\/jmd.19046","article-title":"Modeling alpha-synuclein propagation with preformed fibril injections","volume":"12","author":"Chung","year":"2019","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.neuroscience.2026.02.013_b0065","article-title":"Macular structure and microvasculature changes in AIDS-related cytomegalovirus retinitis using optical coherence tomography angiography","volume":"8","author":"Du","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.013_b0070","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nbd.2011.06.009","article-title":"Rotenone induces degeneration of photoreceptors and impairs the dopaminergic system in the rat retina","volume":"44","author":"Esteve-Rudd","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.013_b0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/mds.23939","article-title":"Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease","volume":"27","author":"Gallagher","year":"2012","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.013_b0080","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajo.2013.09.028","article-title":"Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration","volume":"157","author":"Garcia-Martin","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.neuroscience.2026.02.013_b0085","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fneur.2018.00455","article-title":"On cell loss and selective vulnerability of neuronal populations in Parkinson's disease","volume":"9","author":"Giguere","year":"2018","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.02.013_b0090","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.02.013_b0095","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/mds.27454","article-title":"Oculo-visual abnormalities in Parkinson's disease: possible value as biomarkers","volume":"33","author":"Guo","year":"2018","journal-title":"Mov. Disord."},{"issue":"9766","key":"10.1016\/j.neuroscience.2026.02.013_b0100","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(10)62345-8","article-title":"Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies","volume":"377","author":"International Parkinson Disease Genomics C","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.neuroscience.2026.02.013_b0105","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2967\/jnumed.108.061572","article-title":"Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls","volume":"50","author":"Jokinen","year":"2009","journal-title":"J. Nucl. Med."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.013_b0110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12031-013-0118-1","article-title":"The clathrin-dependent localization of dopamine transporter to surface membranes is affected by alpha-synuclein","volume":"52","author":"Kisos","year":"2014","journal-title":"J. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.013_b0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3233\/JPD-130306","article-title":"Optical coherence tomography in Parkinson's disease: is the retina a biomarker?","volume":"4","author":"Lee","year":"2014","journal-title":"J. Parkinsons Dis."},{"issue":"10","key":"10.1016\/j.neuroscience.2026.02.013_b0120","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","article-title":"alpha-Synuclein misfolding and aggregation: implications in Parkinson's disease pathogenesis","volume":"1867","author":"Mehra","year":"2019","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.013_b0125","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/s11064-012-0706-4","article-title":"Contralateral retinal dopamine decrease and melatonin increase in progression of hemiparkinsonium rat","volume":"37","author":"Meng","year":"2012","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.013_b0130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s13760-020-01274-w","article-title":"Does retina play a role in Parkinson's disease?","volume":"120","author":"Mohana Devi","year":"2020","journal-title":"Acta Neurol. Belg."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.013_b0135","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40478-016-0346-z","article-title":"The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain","volume":"4","author":"Normando","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"issue":"8","key":"10.1016\/j.neuroscience.2026.02.013_b0140","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/mds.27392","article-title":"Phosphorylated alpha-synuclein in the retina is a biomarker of Parkinson's disease pathology severity","volume":"33","author":"Ortuno-Lizaran","year":"2018","journal-title":"Mov. Disord."},{"issue":"43","key":"10.1016\/j.neuroscience.2026.02.013_b0145","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2104689118","article-title":"Dietary omega-3 polyunsaturated fatty acids are protective for myopia","volume":"118","author":"Pan","year":"2021","journal-title":"PNAS"},{"issue":"12","key":"10.1016\/j.neuroscience.2026.02.013_b0150","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2026.02.013_b0155","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fnagi.2017.00214","article-title":"The role of microglia in retinal neurodegeneration: Alzheimer's disease, Parkinson, and glaucoma","volume":"9","author":"Ramirez","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.013_b0160","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/bjophthalmol-2013-304152","article-title":"Retinal thinning and correlation with functional disability in patients with Parkinson's disease","volume":"98","author":"Satue","year":"2014","journal-title":"Br. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.013_b0165","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009399","article-title":"alpha-Synuclein in Parkinson's disease","volume":"2","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.013_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JPD-150769","article-title":"Retrograde axonal degeneration in Parkinson disease","volume":"6","author":"Tagliaferro","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neuroscience.2026.02.013_b0175","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/EB.S193026","article-title":"Optical coherence tomography angiography in neurodegenerative diseases: a review","volume":"12","author":"Tsokolas","year":"2020","journal-title":"Eye Brain"},{"issue":"9","key":"10.1016\/j.neuroscience.2026.02.013_b0180","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00415-018-9051-0","article-title":"Early ophthalmologic features of Parkinson's disease: a review of preceding clinical and diagnostic markers","volume":"266","author":"Turcano","year":"2019","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.013_b0185","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00401-018-01956-z","article-title":"Retinal alpha-synuclein deposits in Parkinson's disease patients and animal models","volume":"137","author":"Veys","year":"2019","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.013_b0190","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41433-022-02056-9","article-title":"Optical coherence tomography as retinal imaging biomarker of neuroinflammation\/neurodegeneration in systemic disorders in adults and children","volume":"37","author":"Vujosevic","year":"2023","journal-title":"Eye (Lond.)"},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2026.02.013_b0195","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s10654-011-9581-6","article-title":"Epidemiology and etiology of Parkinson's disease: a review of the evidence","volume":"26","author":"Wirdefeldt","year":"2011","journal-title":"Eur. J. Epidemiol."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.02.013_b0200","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1080\/02713683.2021.1933054","article-title":"Retinal flow density changes in early-stage parkinson's disease investigated by swept-source optical coherence tomography angiography","volume":"46","author":"Zhang","year":"2021","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.neuroscience.2026.02.013_b0205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroscience.2021.06.033","article-title":"Investigation of alpha-synuclein species in plasma exosomes and the oligomeric and phosphorylated alpha-synuclein as potential peripheral biomarker of Parkinson's disease","volume":"469","author":"Zheng","year":"2021","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.013_b0210","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/ene.14613","article-title":"Optical coherence tomography measurements as potential imaging biomarkers for Parkinson's disease: a systematic review and meta-analysis","volume":"28","author":"Zhou","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuroscience.2026.02.013_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.762394","article-title":"Appearance of tumor vessels in patients with choroidal osteoma using swept-source optical coherence tomographic angiography","volume":"11","author":"Zhou","year":"2021","journal-title":"Front. Oncol."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226001028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226001028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:48:14Z","timestamp":1777556894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226001028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":43,"alternative-id":["S0306452226001028"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.02.013","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The retinal nerve fiber layer mean thickness in patients with early Parkinson\u2019s disease reflects striatal dopamine function","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}